5-METHYL-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDINE
Compound with spectra: 1 NMR
![5-METHYL-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDINE](/api/compound/DXm3npPoTsi.png?ph=true&h=300&w=458 "5-METHYL-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDINE")
| SpectraBase Compound ID | DXm3npPoTsi |
|---|---|
| InChI | InChI=1S/C18H21N3O7/c1-9-5-6-13-17(20-9)21(8-19-13)18-16(27-12(4)24)15(26-11(3)23)14(28-18)7-25-10(2)22/h5-6,8,14-16,18H,7H2,1-4H3/t14-,15-,16-,18-/m1/s1 |
| InChIKey | XQEHBJVKQGQEJC-YFHUEUNASA-N |
| Mol Weight | 391.38 g/mol |
| Molecular Formula | C18H21N3O7 |
| Exact Mass | 391.13795 g/mol |
| Enantiomer InChIKey | XQEHBJVKQGQEJC-OVWQWFNUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
9H-Purine, 2-(methylthio)-9-(2,3,5-tri-O-acetyl-.beta.-D-ribofuranosyl)-
[1-(15)-N]-6-BROMO-9-(2',3',5'-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-9H-PURINE
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
ADENOSINE-TRIACETATE
ALPHA-ADENOSINE-2',3',5'-TRIACETATE
5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-AMINE
5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDINE
2',3'-DI-O-ACETYL-5-DEOXY-5-(FLUOROMETHYLTHIO)ADENOSINE
2',3'-DI-O-ACETYL-5'-S-(FLUOROMETHYL)-5'-THIOADENOSINE
9-(5-S-Methyl-5-thio-2,3-di-O-acetyl-.beta.-D-arabinofuranosyl)adenine
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Nebularine Analogues and Their Inhibitory Activity against Adenosine Deaminase | CHEMICAL & PHARMACEUTICAL BULLETIN | 2015 |